explore -WSS

explore

author：entertainment 2025-09-28 01:30:48 - browse：537

A person wears five fitness tracking watches on their wrist — first opinion coverage from STAT — Bebeto Matthews/AP

Turn on your TV or open a web browser this January, and you’ll be bombarded with ads for fitness trackers, smart scales, health apps, and other digital innovations promising to streamline your journey to a happier and healthier you. It’s the time of year when we’re most susceptible to such messaging: Surveys show that at least one-third of our New Year’s resolutions focus on exercising, losing weight, or eating better.

That’s great news for the $45 billion fitness tracking industry, which spends vast sums on advertising designed to convince us that data is the key to better living. The marketing campaigns work: Each January, fitness app downloads spike 36% higher than usual. We’ve also seen the rise of over 400 personalized nutrition companies, while over 12 million people have sequenced their DNA through 23andMe.

Only one problem: The data isn’t working. At least 1.4 million Americans are diagnosed with diabetes each year. Obesity rates soared from 31% to 42% over the past decade. Life expectancy is declining. We were told data would put us in control, but we’re actually less healthy than ever.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： With psoriasis trial ahead, Alumis raises $259 million

WSS

Pharma budget tightening trickles down to Doximity

Amylyx ALS drug failure raises questions and concerns

White House drug shortages task force keeps mum with Congress

UnitedHealth quietly bought dozens of outpatient centers

Pharma budget tightening trickles down to Doximity

Amylyx ALS drug failure raises questions and concerns

hotspot

explore

focus

Trump demands the U.S. pay no more for drugs than other countries … again

CDC marks new Covid

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

TB outbreak tied to bone grafts underscores testing shortcomings

Medical records are filled with copy

After John Oliver segment, STAT readers share their opioid

Activists slam private health insurers over coverage restrictions

Novo Nordisk obesity pill bests Wegovy in early trial

Apple is now the first public company to be valued at $3 trillion

Target recalls 2.2 million additional candles due to laceration, burn hazards

hotspot

Pharma budget tightening trickles down to Doximity

NEJM study link tiny plastics in blood vessels to heart problems

Amylyx ALS drug failure raises questions and concerns

Novo Nordisk obesity pill bests Wegovy in early trial

With psoriasis trial ahead, Alumis raises $259 million

After John Oliver segment, STAT readers share their opioid

knowledge

knowledge

entertainment

focus